Spectrum
From this contributor
Map of global autism prevalence
View an interactive map of studies on autism prevalence around the world. The map highlights places where information is available — and places where information is missing.
Introducing ‘Synaptic,’ a new podcast from Spectrum
Explore the people, the science and the challenges in autism research.
Journal Club: Meta-analysis oversells popular autism screen
The Modified Checklist for Autism in Toddlers (M-CHAT) accurately flags autistic toddlers, a new systematic review and meta-analysis suggests, contrary to past evidence that the tool’s validity varies depending on a child’s age and traits. Experts weigh in on the discrepancy.
Journal Club: Meta-analysis oversells popular autism screen
40 under 40
In 2022, we asked our profile subjects and sources to flag rising stars in their labs or among their former students. The result is this list of 40 young researchers who are working on autism-related science across the globe.
Hot topics in autism research in 2022
This year saw the debut of ever-more complex techniques to grow and analyze brain organoids and other 3D tissue cultures, among other advances.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.